Image

Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation

Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Investigators assume that surgical correction approach to functional mitral regurgitation during intervention for chronic aortic regurgitation in patients with severe enlargement of the left heart chambers influences reverse remodeling of the left ventricle (LV) in the postoperative period. It is suggested that functional mitral regurgitation (MR) provides supra-physiological left ventricle volume overload and this fact plays positive role in early-stage post-operative left ventricle volume and function recovery. LV volume, systolic and diastolic function will be monitored with echocardiography (EchoCG) along with life quality in patients with different grades of functional mitral regurgitation secondary to severe chronic aortic insufficiency after surgical treatment of aortic regurgitation.

Eligibility

Inclusion Criteria:

  • Age over 18 years
  • Planned primary elective surgery for chronic aortic regurgitation
  • Presence of functional mitral regurgitation
  • End-diastolic volume of the left ventricle >= 250 ml

Exclusion Criteria:

  • Infectious endocarditis
  • History of myocardial infarction
  • Indications on simultaneous myocardial revascularisation
  • Acute aortic regurgitation of any etiology
  • Previously diagnosed dilatation of the left ventricle, not associated with the development of aortic regurgitation
  • Long-term persistent or permanent form of atrial fibrillation
  • Pregnancy in the first 12 months after surgery
  • Simultaneous participation in other studies
  • Presence of implanted pacemakers
  • Refusal to sign informed consent
  • Acute coronary event diagnosed within 12 months after aortic valve surgery
  • Indications for resynchronization therapy or permanent right ventricular pacing in the first 12 months after aortic valve surgery
  • Re-do cardiac surgery for any reason within 12 months after aortic valve surgery

Study details
    Aortic Valve Regurgitation
    Mitral Valve Regurgitation
    Left Ventricle Dilated
    Left Atrium Dilated
    Systolic Left Ventricular Heart Failure
    Diastolic Heart Failure

NCT06805253

Petrovsky National Research Centre of Surgery

15 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.